 |
carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methyl-ethyl]phenoxy]methyl]phenyl]methoxy]-phenyl]iminomethyl]-,ethyl ester |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2002-01-15 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc;900 Ridgebury Road, P.O. Box 368;Ridgefield, Connecticut, 06877 |
Related Access Program